It was also found that therapies with BCAAs did not raise the concentrations of glucose in patients with liver cirrhosis [43,44] and prolonged essential amino acid supplementation (with 62% BCAAs) did not decrease insulin sensitivity in healthy older adults with moderate protein intake [45]. This evidence concerns the gene INS and cirrhosis of liver.